Knowing this, we confirmed our hypothesis that CD4+ T cells must first be activated to promote lymphedema by demonstrating that the absence of the appropriate cognate antigen for the TCR or CD28 prevents the accumulation of the distinct inflammatory infiltrate seen in lymphedematous skin (Fig. 5g–j). The gene discussed is CD4; the disease is lymphedema.